These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 21044358)

  • 1. Stromal microenvironment processes unveiled by biological component analysis of gene expression in xenograft tumor models.
    Yang X; Lee Y; Huang Y; Chen JL; Xing RH; Lussier YA
    BMC Bioinformatics; 2010 Oct; 11 Suppl 9(Suppl 9):S11. PubMed ID: 21044358
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simultaneous analysis of tumor and stromal gene expression profiles from xenograft models.
    Iorns E; Clarke J; Ward T; Dean S; Lippman M
    Breast Cancer Res Treat; 2012 Jan; 131(1):321-4. PubMed ID: 21947683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In Silico cancer cell versus stroma cellularity index computed from species-specific human and mouse transcriptome of xenograft models: towards accurate stroma targeting therapy assessment.
    Yang X; Huang Y; Lee Y; Gardeux V; Achour I; Regan K; Rebman E; Li H; Lussier YA
    BMC Med Genomics; 2014; 7 Suppl 1(Suppl 1):S2. PubMed ID: 25079962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Whole transcriptome profiling of patient-derived xenograft models as a tool to identify both tumor and stromal specific biomarkers.
    Bradford JR; Wappett M; Beran G; Logie A; Delpuech O; Brown H; Boros J; Camp NJ; McEwen R; Mazzola AM; D'Cruz C; Barry ST
    Oncotarget; 2016 Apr; 7(15):20773-87. PubMed ID: 26980748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CASTIN: a system for comprehensive analysis of cancer-stromal interactome.
    Komura D; Isagawa T; Kishi K; Suzuki R; Sato R; Tanaka M; Katoh H; Yamamoto S; Tatsuno K; Fukayama M; Aburatani H; Ishikawa S
    BMC Genomics; 2016 Nov; 17(1):899. PubMed ID: 27829362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of gene expression in prostate cancer epithelial and interstitial stromal cells using laser capture microdissection.
    Gregg JL; Brown KE; Mintz EM; Piontkivska H; Fraizer GC
    BMC Cancer; 2010 Apr; 10():165. PubMed ID: 20426842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In silico ascription of gene expression differences to tumor and stromal cells in a model to study impact on breast cancer outcome.
    Myhre S; Mohammed H; Tramm T; Alsner J; Finak G; Park M; Overgaard J; Børresen-Dale AL; Frigessi A; Sørlie T
    PLoS One; 2010 Nov; 5(11):e14002. PubMed ID: 21124964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intra-tumour heterogeneity of diffuse large B-cell lymphoma involves the induction of diversified stroma-tumour interfaces.
    Sangaletti S; Iannelli F; Zanardi F; Cancila V; Portararo P; Botti L; Vacca D; Chiodoni C; Di Napoli A; Valenti C; Rizzello C; Vegliante MC; Pisati F; Gulino A; Ponzoni M; Colombo MP; Tripodo C
    EBioMedicine; 2020 Nov; 61():103055. PubMed ID: 33096480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leptin as a mediator of tumor-stromal interactions promotes breast cancer stem cell activity.
    Giordano C; Chemi F; Panza S; Barone I; Bonofiglio D; Lanzino M; Cordella A; Campana A; Hashim A; Rizza P; Leggio A; Győrffy B; Simões BM; Clarke RB; Weisz A; Catalano S; Andò S
    Oncotarget; 2016 Jan; 7(2):1262-75. PubMed ID: 26556856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved prognostication of glioblastoma beyond molecular subtyping by transcriptional profiling of the tumor microenvironment.
    Jeanmougin M; Håvik AB; Cekaite L; Brandal P; Sveen A; Meling TR; Ågesen TH; Scheie D; Heim S; Lothe RA; Lind GE
    Mol Oncol; 2020 May; 14(5):1016-1027. PubMed ID: 32171051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. XactMice: humanizing mouse bone marrow enables microenvironment reconstitution in a patient-derived xenograft model of head and neck cancer.
    Morton JJ; Bird G; Keysar SB; Astling DP; Lyons TR; Anderson RT; Glogowska MJ; Estes P; Eagles JR; Le PN; Gan G; McGettigan B; Fernandez P; Padilla-Just N; Varella-Garcia M; Song JI; Bowles DW; Schedin P; Tan AC; Roop DR; Wang XJ; Refaeli Y; Jimeno A
    Oncogene; 2016 Jan; 35(3):290-300. PubMed ID: 25893296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The molecular signature of the stroma response in prostate cancer-induced osteoblastic bone metastasis highlights expansion of hematopoietic and prostate epithelial stem cell niches.
    Özdemir BC; Hensel J; Secondini C; Wetterwald A; Schwaninger R; Fleischmann A; Raffelsberger W; Poch O; Delorenzi M; Temanni R; Mills IG; van der Pluijm G; Thalmann GN; Cecchini MG
    PLoS One; 2014; 9(12):e114530. PubMed ID: 25485970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biological Misinterpretation of Transcriptional Signatures in Tumor Samples Can Unknowingly Undermine Mechanistic Understanding and Faithful Alignment with Preclinical Data.
    Fisher NC; Byrne RM; Leslie H; Wood C; Legrini A; Cameron AJ; Ahmaderaghi B; Corry SM; Malla SB; Amirkhah R; McCooey AJ; Rogan E; Redmond KL; Sakhnevych S; Domingo E; Jackson J; Loughrey MB; Leedham S; Maughan T; Lawler M; Sansom OJ; Lamrock F; Koelzer VH; Jamieson NB; Dunne PD
    Clin Cancer Res; 2022 Sep; 28(18):4056-4069. PubMed ID: 35792866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determining epithelial contribution to in vivo mesenchymal tumour expression signature using species-specific microarray profiling analysis of xenografts.
    Purdom E; Restall C; Busuttil RA; Schluter H; Boussioutas A; Thompson EW; Anderson RL; Speed TP; Haviv I
    Genet Res (Camb); 2013 Feb; 95(1):14-29. PubMed ID: 23497823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stromal SNAI2 Is Required for ERBB2 Breast Cancer Progression.
    Blanco-Gómez A; Hontecillas-Prieto L; Corchado-Cobos R; García-Sancha N; Salvador N; Castellanos-Martín A; Sáez-Freire MDM; Mendiburu-Eliçabe M; Alonso-López D; De Las Rivas J; Lorente M; García-Casas A; Del Carmen S; Abad-Hernández MDM; Cruz-Hernández JJ; Rodríguez-Sánchez CA; Claros-Ampuero J; García-Cenador B; García-Criado J; Orimo A; Gridley T; Pérez-Losada J; Castillo-Lluva S
    Cancer Res; 2020 Dec; 80(23):5216-5230. PubMed ID: 33023950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hu/Mu ProtIn oligonucleotide microarray: dual-species array for profiling protease and protease inhibitor gene expression in tumors and their microenvironment.
    Schwartz DR; Moin K; Yao B; Matrisian LM; Coussens LM; Bugge TH; Fingleton B; Acuff HB; Sinnamon M; Nassar H; Platts AE; Krawetz SA; Linebaugh BE; Sloane BF
    Mol Cancer Res; 2007 May; 5(5):443-54. PubMed ID: 17510311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Breast tumors educate the proteome of stromal tissue in an individualized but coordinated manner.
    Wang X; Mooradian AD; Erdmann-Gilmore P; Zhang Q; Viner R; Davies SR; Huang KL; Bomgarden R; Van Tine BA; Shao J; Ding L; Li S; Ellis MJ; Rogers JC; Townsend RR; Fenyö D; Held JM
    Sci Signal; 2017 Aug; 10(491):. PubMed ID: 28790197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibiting YAP expression suppresses pancreatic cancer progression by disrupting tumor-stromal interactions.
    Jiang Z; Zhou C; Cheng L; Yan B; Chen K; Chen X; Zong L; Lei J; Duan W; Xu Q; Li X; Wang Z; Ma Q; Ma J
    J Exp Clin Cancer Res; 2018 Mar; 37(1):69. PubMed ID: 29587800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular profiling of microinvasive breast cancer microenvironment progression.
    Lessi F; Scatena C; Aretini P; Menicagli M; Franceschi S; Naccarato AG; Mazzanti CM
    J Transl Med; 2019 Jun; 17(1):187. PubMed ID: 31159827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of prognosis-related genes in the cervical cancer immune microenvironment.
    Yang L; Yang Y; Meng M; Wang W; He S; Zhao Y; Gao H; Tang W; Liu S; Lin Z; Li L; Hou Z
    Gene; 2021 Jan; 766():145119. PubMed ID: 32946928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.